MANCHESTER, N.H., Feb. 24, 2014 /PRNewswire/ -- Emerson Ecologics, LLC, the leading provider of the highest quality professional nutritional supplements to healthcare practitioners and their patients ...

Takeda has allied with ProThera Biologics to develop a plasma-derived inter-alpha inhibitor proteins (IAIP) therapy for use in acute inflammatory conditions. The deal advances Takeda’s efforts to ...

ProThera Biologics Inc., an East Providence, R.I.-based developer of inter-alpha inhibitor proteins, has raised $500,000 from The Slater Technology Fund. The company hopes to help treat inflammatory ...

PROVIDENCE, R.I., and OSAKA, Japan, April 23, 2020 /PRNewswire/ -- ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited [TSE:4502/NYSE:TAK] ("Takeda") today announced that they have ...

ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") announced today that it has entered into a strategic partnership with ProThera Biologics Inc. ("ProThera") for ...

ProMetic Life Sciences Inc., a biopharmaceutical company, has entered into a strategic partnership with ProThera Biologics Inc. (ProThera), a biotechnology company, for the development and ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Prothera's new monoclonal antibody drug ("PRX002") did more than just pass its Phase I safety test - it scored a ...

East Providence-based ProThera Biologics, a company that works to develop proteins for the therapeutic treatment of life-threatening inflammatory conditions, has received a $2.03 million Small ...

Location: East Providence, R.I. Web: www.protherabiologics.com Phone: 401-301-2046 Founded: 2001 Top executive: Yow-Pin Lim, president and chief scientific officer Industry: Biomedical Biomedical ...

ProThera Biologics LLC, a biomedical company spun out of the research labs of the Lifespan hospital system, has obtained $750,000 in new funding. The financing comprised a $500,000 grant from the ...

* TAKEDA - ENTERED LICENSING AGREEMENT WITH PROTHERA TO DEVELOP A NOVEL PLASMA-DERIVED IAIP THERAPY FOR TREATMENT OF ACUTE INFLAMMATORY CONDITIONS * TAKEDA PHARMACEUTICAL CO LTD - FINANCIAL TERMS OF ...